Cases 71 - 80 of 404
Keryx Biopharmaceuticals, Inc et al v. Mylan Pharmaceuticals Inc.
as 1:2019cv01445
Plaintiff:
Panion & BF Biotech, Inc., Keryx Biopharmaceuticals, Inc. and Chen Hsing Hsu
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
In re: Auryxia (Ferric Citrate) Patent Litigation
as 1:2019md02896
Not Classified By Court:
Chemo Research S.L., Insud Pharma S.L., Teva Pharmaceuticals USA, Inc. and others
Counter Defendant:
Keryx Biopharmaceuticals, Inc., Panion & BF Biotech, Inc. and Chen Hsing Hsu
Counter Claimant:
Lupin Atlantis Holdings SA and Lupin Ltd.
In Re:
In re: Auryxia (Ferric Citrate) Patent Litigation
Cause Of Action: 35 U.S.C. § 271
AMGEN INC et al v. MYLAN INC. et al
as 2:2017cv01235
Defendant:
MYLAN GMBH, MYLAN PHARMACEUTICALS INC, MYLAN INC. and others
Plaintiff:
AMGEN INC and AMGEN MANUFACTURING LIMITED
Petitioner:
HOSPIRA, INC.
Cause Of Action: 35 U.S.C. § 271
JANSSEN PHARMACEUTICALS, INC. et al v. MYLAN LABORATORIES LIMITED et al
as 2:2019cv16484
Plaintiff:
JANSSEN PHARMACEUTICA NV and JANSSEN PHARMACEUTICALS, INC.
Defendant:
MYLAN PHARMACEUTICALS INC., MYLAN LABORATORIES LIMITED and MYLAN INSTITUTIONAL LLC
Cause Of Action: 28 U.S.C. § 1338
Takeda Pharmaceuticals U.S.A., Inc. v. Mylan Pharmaceuticals Inc.
as 1:2019cv02216
Defendant:
Mylan Pharmaceuticals Inc.
Plaintiff:
Takeda Pharmaceuticals U.S.A., Inc.
3Rd Party Defendant:
Hikma Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc.
Intervenor:
Par Pharmaceutical Inc.
Cause Of Action: 35 U.S.C. § 271
Celgene Corporation v. Mylan Pharmaceuticals Inc. et al
as 1:2020cv00003
Plaintiff:
Celgene Corporation
Defendant:
Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan, N.V.
Cause Of Action: 35 U.S.C. § 145
In re: Kerydin (Tavaborole) Topical Solution 5% Patent Litigation
as 1:2019md02884
Counter Claimant:
Glasshouse Pharmaceuticals Limited Canada
Not Classified By Court:
Taro Pharmaceuticals U.S.A., Inc., Aurobindo Pharma Limited, Zydus Pharmaceuticals (USA) Inc. and others
In Re:
Kerydin (Tavaborole) Topical Solution 5% Patent Litigation
Counter Defendant:
Anacor Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Dr. Reddys Laboratories, Inc. et al
as 1:2019cv02053
Defendant:
MSN Laboratories Private Limited, Dr. Reddys Laboratories, Inc., Hetero USA Inc. and others
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc. et al
as 1:2019cv00201
Defendant:
Mylan Laboratories Limited, Mylan Pharmaceuticals Inc. and Mylan Inc.
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
Pfizer Inc. et al v. Mylan Pharmaceuticals Inc.
as 1:2019cv01863
Plaintiff:
Warner-Lambert Company LLC, PF Prism C.V., Pfizer Manufacturing Holdings LLC and others
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
